Começar
Pokethebear

AVEO missed earnings - kidney cancer treatment too thinly traded

Viés de alta
Pokethebear Atualizado   
NASDAQ:AVEO   None
Fibonacci Supply and Demand Beyond Technical Analysis oncology kidney pharmaceuticals pharmastocks clinical fullretracement NEW LOW entrypoint
2
0
fibonacci supplyanddemand beyondta oncology kidney pharmaceuticals pharmastocks clinical fullretracement new low entrypoint
Medical stock that's too thinly traded got mixed review on clinical trial results on Tivozanib, which showed efficacy, just not to level expected and testing new low for 2018 at 2.03 and below full fibonacci retracement of 2.10 as prior low. NASDAQ:AVEO
Comentário:
snapshot
Currently at 618fibretracement
Comentário:
Full 241% retracement and bounce to 161%. Sign of bouncing cat?
Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.